🇺🇸 FDA
Patent

US 7632932

Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase

granted A61KA61K31/7115

Quick answer

US patent 7632932 (Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase) held by Alnylam Pharmaceuticals, Inc. expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/7115